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Cognitive deficits in schizophrenia are pervasive, severe, and largely independent of the positive and negative symptoms of 
the illness. These deficits are increasingly considered to be core features of schizophrenia with evidence that the extent of 
cognitive impairment is the most salient predictor of daily functioning. Unfortunately, current schizophrenia treatment has been 
limited in addressing the cognitive deficits of the illness. Alterations in neuroplasticity are hypothesized to underpin these cognitive 
deficits, though preserved neuroplasticity may offer an avenue towards cognitive remediation. Key neuroplastic principles to 
consider in designing remediation interventions include ensuring sufficient intensity and duration of remediation programs, 
"bottom-up" training that proceeds from simple to complex cognitive processes, and individual tailoring of remediation regimens. 
We discuss several cognitive remediation programs, including cognitive enhancement therapy, which embrace these principles 
to target neurocognitive and social cognitive improvements and which havebeen demonstrated to be effective in schizophrenia. 
Future directions in cognitive remediation research include potential synergy with pharmacologic treatment, non-invasive stim-
ulation techniques, and psychosocial interventions, identification of patient characteristics that predict outcome with cognitive 
remediation, and increasing the access to these interventions in front-line settings.
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Neuronal plasticity.
COGNITIVE DEFICITS ARE A CORE 
ASPECT OF SCHIZOPHRENIA
Cognitive deficits in schizophrenia have been identi-
fied as early as Kraeplin’s original description of “demen-
tia praecox,” meaning cognitive decline with onset in 
youth. They are widely suggested to be a core feature of 
schizophrenia with increasing support for including im-
pairments in cognition in the diagnostic criteria of the 
illness.
1,2) Extensive research has documented global cog-
nitive impairment in schizophrenia, encompassing decre-
ments in verbal and non-verbal memory, attention, execu-
tive function, processing speed, spatial ability, and 
abstraction.
3) Moreover, the extent of these deficits is sub-
stantial, such that patients with schizophrenia tend to test 
at one to two standard deviations below the mean for 
healthy controls.
4,5) Cognitive deficits are highly preva-
lent in schizophrenia, with estimates that as many as 98% 
of schizophrenia patients demonstrate impairment rela-
tive to their predicted cognitive function based on pre-
morbid estimates of intelligence and parental education 
levels.
6) These impairments are identifiable early in the ill-
ness, prior to treatment with antipsychotic medication, 
and persist throughout the course of the illness, further ar-
guing for inclusion as core elements of schizophrenia.
6,7) 
While there is often speculation that measurement of cog-
nitive functioning in schizophrenia is distorted by the 
presence of positive symptoms, no correlation between 
these measures was found in either the Clinical Antipsyc-
hotic Trials of Intervention Effectiveness (CATIE) trial or 
previous research examining these symptom groups.
8-11) 
Studies that examined cognitive functioning during both a 
psychotic episode and after the psychosis was in re-
mission in the same group of patients found that cognitive 
performance was similar at both time points.
12) While neg-
ative symptoms and cognitive impairment are slightly 
correlated, the fact that only 15% of the variance is attrib-
utable to the negative symptoms suggests that deficits in 
cognition exist as an independent feature of schizo-
phrenia.
13) Because unaffected first-degree relatives of 126 Y. Kaneko and M. Keshavan
schizophrenia patients demonstrate a pattern of cognitive 
deficits that is similar to that of the patients themselves, it 
is unlikely that the patients’ cognitive impairments are 
simply secondary to schizophrenia symptoms or treat-
ment.
14,15)
    Finally, the nature of cognitive deficits in schizophrenia 
is distinct from the impairments observed in other neuro-
psychiatric and neurodevelopmental disorders. The cog-
nitive domains most impacted in schizophrenia include 
memory, attention, reasoning, problem solving, and social 
cognition.
16) Although patients with affective psychoses 
may present with a similar pattern of deficits, the magni-
tude of the deficits in schizophrenia is substantially 
greater.
17) A meta-analysis comparing cognitive deficits in 
patients with schizophrenia and bipolar disorder who had 
similar clinical and demographic characteristics demon-
strated the impairments in schizophrenia to be, on aver-
age, 0.5 standard deviations greater than those in bipolar 
disorder.
18) Importantly, cognitive performance in schizo-
phrenia appears to be stable across fluctuations in illness 
symptoms, while deficits in affective disorders are more 
closely tied to clinical state.
10,17) In a study of patients with 
psychosis, only those who had bipolar disorder had im-
provements in cognitive function with the resolution of 
the psychosis while those with schizophrenia performed 
at the same level cognitively regardless of changes in psy-
chotic symptoms.
19) Moreover, patients who go on to de-
velop schizophrenia exhibit cognitive decline over the 
course of childhood and adolescence which occurs prior 
to the onset of psychotic symptoms.
20) Conversely, those 
patients who go on to develop affective disorders do not 
demonstrate cognitive deficits until their affective symp-
toms have presented.
21) Although social cognition is im-
paired in both schizophrenia and autism, the two disorders 
can be distinguished by relative preservation of basic so-
cial perceptual mechanisms in schizophrenia, wherein ab-
normalities are tied to deficits in higher order social cogni-
tive processes.
22) While cognitive deficits are widespread 
in neuropsychiatric disorders, the pattern and magnitude 
of these deficits in schizophrenia enables this disorder to 
be distinguished.
    Cognitive deficits  in schizophrenia are significantly 
correlated with functional outcome with regards to em-
ployment, independent living, community functioning, 
and social functioning.
23-27) Indeed, the link between cog-
nitive performance and functional outcome is sub-
stantially stronger than that between psychosis and func-
tional outcome.
13) While first generation antipsychotics 
can address the positive symptoms of schizophrenia, they 
appear to have modest, if any, effect on cognitive 
performance.
28,29) There was initial hope based on pre-
clinical data that second generation antipsychotics would 
be more effective in improving cognitive performance. 
Subsequent clinical studies, however, have not demon-
strated any meaningful difference in their effect on cogni-
tion between the first and second generation antipsy-
chotics.
30,31)
COGNITIVE DEFICITS AND NEUROPLASTICITY
    The above observations underscore the identification of 
cognitive deficits as a core feature of schizophrenia and a 
key path toward understanding the etiopathology of this 
illness. In recent years, there has been increasing evidence 
that the core cognitive deficits in schizophrenia may stem 
from neurodevelopmentally-mediated alterations in brain 
plasticity.
    Neural plasticity refers to the ability of neural circuits to 
alter their structure, function, and connectivity in response 
to experience. Over 50 years ago, Hebb
32) postulated that 
synaptic plasticity is predicated on changes in synaptic ef-
ficacy, whereby repeated and persistent stimulation of the 
postsynaptic cell by the presynaptic cell increases the 
functional strength of the synapse connecting them. 
Experimental demonstration of this process, termed 
long-term potentiation (LTP), is accepted as a physiologic 
process underpinning learning and memory.
33) Since the 
identification of LTP, numerous other mechanisms of 
plasticity have been identified, with complex interactions 
between the different forms of plasticity and the networks 
in which they operate. There is increasing evidence that 
this plasticity is central to understanding both normal and 
disordered neural functioning.
34) While the exact mecha-
nism of cognitive impairment in schizophrenia remains to 
be elucidated, disconnectivity within neural networks is 
gaining prominence as a theoretical model for functional 
impairment.
35) It is thought that abnormal neuroplasticity 
underlies this disconnectivity and therefore plays a central 
role in the cognitive deficits of schizophrenia. Evidence 
for this altered plasticity is converging along multiple 
lines, including studies in neurophysiology, neurophar-
macology, neuropathology, and genetics.
36) For example, 
a study of neural plasticity using transcranial magnetic 
stimulation (TMS) demonstrated abnormal plasticity in 
both medicated and unmedicated patients with schizo-
phrenia relative to healthy controls.
37) Similarly, plasticity 
measured by electrophysiological responses to auditory 
conditioning is reduced in schizophrenia.
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logic agents, such as N-methyl D-aspartic acid (NMDA) 
antagonists, that can reproduce both the psychotic symp-
toms and cognitive deficits observed in schizophrenia 
have also been shown to affect neural plasticity.
39) Genetic 
studies consistently implicate altered synaptic plasticity in 
the pathogenesis of schizophrenia, as many of the stron-
gest candidate genes for schizophrenia influence the de-
velopment and regulation of neural networks.
40,41) Thus, it 
is increasingly believed that changes in neural plasticity 
may underlie the cognitive deficits and other clinical fea-
tures of schizophrenia.
NEUROPLASTICITY AS A THERAPEUTIC 
TARGET IN SCHIZOPHRENIA
    The significant personal and societal costs of schizo-
phrenia highlight the importance of evidence-based inter-
ventions to reduce long-term morbidity. Unfortunately, to 
date, few successful efforts have been directed toward the 
treatment of cognitive deficits in schizophrenia, and clear-
ly, alternate therapeutic targets are critically needed. In 
this context, the potential for employing the surviving 
functional neuroplasticity for therapeutic gain in schizo-
phrenia and other neuropsychiatric disorders is of increas-
ing importance.
    Neuroplasticity is known to underlie functional recov-
ery in a broad array of clinical conditions, including 
stroke, trauma, and spinal cord injuries. In a review of 
plasticity and training in animal models of the post-ische-
mic milieu, for example, Komitova et al.
42) documented 
changes in cortical thickness, brain weight, gene ex-
pression, dendritic branching, and cortical mapping that 
were associated with an enriched environment. Exposure 
to enriched environments is analogous to learning through 
training with similar mechanisms at play in modifying 
brain function.
43) Spontaneous clinical improvement in 
stroke, trauma, and spinal cord injuries is associated with 
observable changes at both the cellular level and within 
the functional connectivity of the relevant neural net-
works.
44) Moreover, therapies designed to employ the 
brain’s plasticity have been shown to mimic or exceed 
these changes. For example, studies of post-stroke thera-
pies demonstrate both restoration of functional organ-
ization and creation of neuronal projections
45-47) while 
similar studies of brain or spinal cord injuries correlate 
clinical improvement with observable changes in func-
tional and structural neuroimaging.
48,49) There has been in-
creasing interest in the possibility of involving neuro-
plasticity in the treatment of psychiatric disorders. Just as 
physical rehabilitation in the setting of trauma to the nerv-
ous system leads to functional improvement of the motor 
system, cognitive training is being developed across a va-
riety of clinical conditions, from neurodevelopmental dis-
orders
50) to aging
51) to neuropsychiatric illnesses, includ-
ing schizophrenia.
52,53) Such work has lead to the hypoth-
esis that cognitive deficits in schizophrenia could be miti-
gated by treatment designed to improve the brain’s struc-
tural and functional integrity via neuroplasticity. Cogni-
tive remediation approaches seek to address this goal; we 
discuss herein, using physical exercise as an analogy, the 
key principles underlying the application of neuro-
plasticity in developing these interventions.
The More One Exercises, the Better
Evidence for neuroplasticity and reshaping of neural 
networks that is both time-dependent and reliant upon re-
petitive training converges across a number of research 
modalities. Animal models demonstrate two distinct proc-
esses in the development of LTP. In the first phase, there is 
increased synaptic efficiency, such that an increased num-
ber of the signals that reach the presynaptic cell are passed 
on to the postsynaptic cell.
54) This is mediated initially by 
post-synaptic glutamatergic NMDA receptors that detect 
coincident activity and induce both pre-synaptic and post-
synaptic changes to increase efficiency.
33) Alpha-ami-
no-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) 
receptors, via either increased insertion at the postsynaptic 
membrane or modification of their signaling properties, 
seem to be the mechanism by which this efficiency is 
induced.
55,56) Analogous to the molecular mechanisms at 
play in LTP, human skill learning across multiple domains 
demonstrates rapid, but unsustained, initial learning.
57) 
Non-specific mechanisms, such as temporary changes in 
cortical representations, top-down organization related to 
task performance, and the increases in synaptic efficiency 
and neuronal excitability discussed above mediate this in-
itial phase of performance improvement.
58,59) Topographi-
cally, the rapid phase of learning is associated with activa-
tion and increased functional connectivity of regions in-
volved in directed attention, such as the prefrontal cortex, 
anterior cingulate cortex, and posterior parietal cor-
tex.
60,61) These changes are not task-specific, but rather re-
flect generic heightened attention and effort resulting in 
activation of a set of regions now known as the task-pos-
itive network.
62)
    In contrast to these mechanisms, the second phase of 
LTP and learning is predicated upon synaptogenesis and 
reorganization of cortical representations.
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LTP is associated with an increased number of functional 
synaptic sites between hippocampal neurons in the rat 
brain.
64) Moreover, studies of rat hippocampal slices dem-
onstrate that it is repetitive induction of late-phase LTP, 
rather than transitory excitation, that results in the gen-
eration of new synaptic structures.
65) Given its slower time 
course and development with continued activity, synapto-
genesis may contribute to the maintenance and stability of 
synaptic potentiation, thus underscoring the importance 
of sustained activity for achieving long-term functional 
changes.
54) Whereas early phase learning is associated 
with activation of general attentional areas comprising the 
task-positive network, sustained learning is associated 
with regional activation with higher task specificity.
66,67) 
That is, as a performance becomes more practiced, it is in-
creasingly linked to activation of the specific neural sys-
tems that underpin it and decreasingly reliant on top-down 
attention. For example, the second phase of learned motor 
tasks results in increased activation of the motor areas of 
the brain, including the supplementary motor area, cingu-
late motor cortex, cerebellum, and basal ganglia, at the 
same time that decreased activation of the task-positive 
network is observed.
68,69) In higher-order cognitive tasks, 
this reorganization may be represented not by increases in 
activity within a given region, but rather by increased 
functional connectivity in a distributed neural net-
work.
67,70) In order for neuroplasticity-mediated learning 
to result in durable functional changes, therefore, it is vital 
that the training be of sufficient duration to engage the sec-
ond phase of learning. For example, a meta-analysis of 
cognitive remediation in schizophrenia, found that in-
creased hours of remediation were associated with a larger 
effect size in verbal learning and verbal memory.
71) 
Vinogradov et al.
58) suggest that the relatively low in-
tensity and brief duration of the studies of cognitive re-
mediation to date may explain the fact that such 
meta-analyses have yet to document persistent, significant 
benefits to cognitive remediation. Future studies, there-
fore, will need to document the extent of treatment re-
quired to produce lasting results in order that adequate in-
terventions be tested.
Simple Exercise Should Precede Complex Tasks
The second analogy to physical training is that it is bet-
ter to start “bottom-up” with simple exercises, and gradu-
ally progress to more complex tasks.
    Cognitive remediation approaches are likely to be more 
effective if simple cognitive processes are mastered be-
fore higher-level processes are addressed. Cognitive load 
theory formalizes this relationship, identifying increased 
ease of knowledge acquisition for information that builds 
upon existing knowledge relative to entirely novel infor-
mation.
72) The known information enables more efficient 
processing of information such that an increasing pro-
portion of the cognitive load is devoted to learning and 
problem solving.
73) A corollary to this statement is that im-
paired processing of simple information will undermine 
higher-order manipulation of this operation. Indeed, in 
schizophrenia patients, deficits in basic perceptual skills 
have been identified and shown to compromise perform-
ance of more complex cognitive operations.
74) For exam-
ple, impairments in a tone-matching task, in which sub-
jects are asked to determine if two tones are identical or 
not, are linked to deficits in the ability to interpret another 
person’s emotions based on auditory information.
75) 
Similarly, deficits in the processing of syllables are related 
to decreases in verbal learning and general cognition in 
both schizophrenia patients and healthy controls.
76) 
Because deficits in simple perception necessitate an in-
creased attentional load and recruitment of top-down op-
erations to achieve basic processing,
77) fewer top-down 
resources are available for higher-level cognitive 
operations.
78)
    Given this connection, there is increasing emphasis on 
the idea that training targeting basic sensory processes and 
simple cognitive functions will ultimately benefit high-
er-level cognitive operations. A study of aging adults 
demonstrated that training that produced improvement in 
early visual processing lead to improvements in working 
memory.
79) Similar studies are beginning to emerge in 
schizophrenia research. For example, Adcock et al.
77) 
have shown that an auditory training regimen can induce 
improvements in impaired sensory processing, such as the 
ability to distinguish two similar syllables. More im-
portantly, they demonstrated that these basic improve-
ments were associated with improvements in higher order 
functions, including linguistic processing, verbal cogni-
tion, and general cognition and that these changes were 
durable six months after training had concluded.
77) 
Similarly, a social cognition training regimen that in-
cluded practice in the basic skill of emotion perception 
was demonstrated to improve not only social cognition, 
but also social functioning in patients with schizophrenia, 
suggesting that the benefits generalize from test perform-
ance to actual functioning.
80) Cognitive therapies, there-
fore, must both recognize and address the perceptual proc-
essing impairments that are present in schizophrenia if 
maximal improvements in higher order cognitive func-Cognitive Remediation in Schizophrenia 129
tions are to be achieved.
Personalized Exercises Work Better
Finally, and again by analogy to physical exercise, in-
terventions are most effective if they are tailored in-
dividually to each person’s capabilities and limitations
An important aspect of individual tailoring of one’s ex-
ercise regime is to monitor performance and gradually in-
crease the difficulty; if too hard, one makes errors, and if 
too easy, the task gets boring. For maximal benefit there-
fore, it is important to have the tasks slightly above the 
threshold of challenge.
81) Studies of learning and neuro-
plasticity conducted in the elderly demonstrate the im-
portance of balancing attention, reward, and novelty in or-
der to produce efficient learning. It is the balance of these 
features that lead to optimal engagement of the neuro-
modulatory systems, including the acetylcholine, dop-
amine, norepinephrine, and serotonin signaling systems, 
which in turn modulate plasticity.
82) The need to maintain 
this balance implies a need for training to increase in diffi-
culty as increased learning occurs such that training re-
mains at threshold. The importance of this principle is high-
lighted by a study of working memory training in patients 
with attention deficit hyperactivity disorder (ADHD) in 
which a training program with graded difficulty pro-
gression resulted in cognitive improvement while the 
same exercise organized in a non-progressive way did not 
lead to increased performance.
83)
One of the learning approaches that has been observed 
to enhance learning is “errorless learning,” that is, in-
tensive training at threshold. In contrast to conventional 
trial and error learning, which requires the learner to re-
member and incorporate feedback, errorless learning is 
based on repetitive exposure designed for the learner to 
succeed in a majority of trials, with difficulty gradually in-
creasing as the learner develops mastery. Errorless learn-
ing takes advantage of implicit (learning without con-
scious awareness) learning processes that may be intact in 
schizophrenia;
84,85) treatment induced improvements in 
implicit learning systems may thus help to restore im-
paired working memory and explicit memory pro-
cesses.
58) Errorless learning has been demonstrated to be 
effective in schizophrenia patients in both formal memory 
assessments and a study of work performance carried out 
in a community mental health center setting.
86,87) Learning 
is also enhanced by personally salient stimuli. There is 
overwhelming evidence that emotionally-charged events 
enhance selective memory consolidation, perhaps medi-
ated by the amygdale;
88) emotionally-charged events are 
remembered better than emotionally neutral experiences, 
and emotion may enhance the subjective sense of recol-
lection more than memory accuracy.
89) Cognitive thera-
pies that manage to personally engage the learner are thus 
more likely to produce meaningful and lasting improve-
ment.
COGNITIVE REMEDIATION APPROACHES
Cognitive remediation is an intervention that seeks to 
enhance the neurocognitive skills in patients relevant to 
their recovery goals. Two distinct and complementary 
cognitive remediation approaches have been developed: 
the compensatory and the restorative approaches. Com-
pensatory approaches utilize environmental supports and 
adaptive strategies to bypass cognitive deficits and im-
prove target behaviors and functional outcomes in in-
dividuals with schizophrenia.
90) In this paper, we focus on 
cognitive restoration approaches that seek to improve def-
icits in one or another cognitive function.
Wagner
91) and Spaulding et al.
92) were among the first 
investigators to show that cognitive deficits in schizo-
phrenia respond to remedial training. Several remediation 
approaches have since been developed, ranging from 
computer-based to paper and pencil and drill-and-practice 
to therapist-guided strategy coaching. These therapies re-
ly on a range of basic cognitive processes, including per-
ception, working memory, attention, and social cognition, 
along with combinations of these functions. In a meta- 
analysis of 26 studies, McGurk et al.
71) found mean effect 
sizes of 0.41 for cognitive improvement and 0.36 for func-
tional outcome. While effect sizes did not differ with re-
gard to the type of remediation, a larger effect size in ver-
bal memory was associated with more hours of re-
mediation (0.57) compared with fewer hours (0.29).
71) A 
more recent meta-analysis of 40 cognitive remediation 
studies conducted between 1973 and 2009 demonstrated a 
mean global cognition effect size of 0.45.
53) Clearly, the 
effect sizes, though significant, were modest. Functional 
outcomes were significantly better in studies where cogni-
tive remediation was combined with some other form of 
rehabilitation and when it included strategy coaching. 
Interventions are likely to be more successful when the 
skills trained closely approximate those needed in daily 
life. There is also evidence that patient variables such as 
levels of intrinsic and extrinsic motivation interact with 
treatment variables to produce a beneficial response to 
cognitive remediation. Going forward, better, multi-com-
ponent strategies to enhance the therapeutic efficacy of 130 Y. Kaneko and M. Keshavan
cognitive remediation need to be identified. In designing 
effective cognitive remediation approaches, it is also im-
portant to adhere to the neuroscientific principles dis-
cussed earlier, i.e., an effective combination of drill and 
practice, “bottom-up” and “top-down” approaches, and 
personalized adaptation of training. Cognitive training ap-
proaches that are intrinsically motivating, used in a mean-
ingful game-like context, those that personalize learning 
materials into themes of high interest value, and those that 
maximize patient control over the learning process are 
likely to be the most effective.
93)
Cognitive enhancement therapy (CET) is a multi-com-
ponent cognitive remediation approach, pioneered by the 
late Professor Gerard E. Hogarty in our group in Pitts-
burgh, that incorporates all of the above principles 
(cognitiveenhancementtherapy.com).
94) CET is designed 
to provide enriched cognitive experiences through tar-
geted and integrated neurocognitive and social-cognitive 
training. The focus is on enhancing both “bottom-up” 
processing of critical social stimuli, with “top-down” ex-
ecutive control over distracting information and emo-
tional arousal. Through the integration of computer-based 
cognitive exercises in attention, training, and prob-
lem-solving, with an active social-cognitive group experi-
ence designed to facilitate perspective-taking, gistful 
processing of information, and social context appraisal, 
CET is thought to provide the requisite experiences need-
ed to enhance neural processing and achieve adult cogni-
tive milestones. The intervention involves weekly ses-
sions for up to two years.
Evidence to date indicates that CET can successfully 
improve social and non-social cognitive impairments in 
schizophrenia. In a randomized-controlled study of 121 
patients with chronic schizophrenia, Hogarty et al.
95) dem-
onstrated significant improvements in cognitive measures 
such as neurocognition, processing speed, and cognitive 
style in patients receiving CET relative to those under-
going enriched supportive therapy. This differential was 
evident in the first year of training and continued to in-
crease throughout the two-year training period. Similarly, 
a study of CET in patients with early-course schizo-
phrenia or schizoaffective disorder identified ongoing im-
provement in cognitive measures from year one to year 
two of treatment.
94) While CET demonstrated only moder-
ate beneficial effect size (d=0.46) in enhancing neuro-
cognitive function, strong differential effects (d＞1.00) 
favoring CET on social cognition, cognitive style, and so-
cial adjustment composites were observed.
94) These find-
ings echoed a previous study demonstrating improve-
ments in social cognition following CET in early course 
schizophrenia.
23) Improvement in the employment rates 
and of patients in the CET cohort suggests that the benefits 
extend beyond formal testing to daily functioning.
94) This 
functional improvement was mediated by neurocognitive 
gains, primarily in executive functioning, and social-cog-
nitive gains in emotion management.
52) Importantly, fol-
low-up studies of each of these groups showed persistence 
in the functional benefits of CET at one-year post-treat-
ment, suggesting that the therapy had engaged the learn-
ing mechanisms necessary for sustained change.
96,97)
The therapeutic effects of CET may capitalize on brain 
plasticity processes to offer neuroprotection and im-
proved brain function in the fronto-temporal areas im-
plicated in cognitive impairment.
52) Over the course of 
two years, schizophrenia patients receiving CET had 
greater preservation of gray matter volume in the left hip-
pocampus, parahippocampal gyrus, and fusiform gyrus, 
and significantly greater gray matter increases in the left 
amygdala compared with those who received enriched 
supportive therapy.
98) Gray matter preservation in the left 
parahippocampal and fusiform gyrus and greater gray 
matter increases in the left amygdala were significantly re-
lated to improved cognition.
98) These structural changes 
are likely mediated by neuroplasticity in the relevant sig-
naling networks and may be the mechanism by which the 
beneficial cognitive effects of CET occur. Interestingly, 
pre-treatment whole brain cortical surface area and gray 
matter volume (“cortical reserve”) significantly mod-
erated the effects of CET on social cognition, though not 
on neurocognition.
99) Greater cortical reserve, particularly 
in the temporal cortex, predicted a rapid social-cognitive 
response to CET in the first year of treatment. Given the 
fact that patients with less neurobiological reserve ach-
ieved a comparable social-cognitive response by the sec-
ond year, however, it is possible that the early response re-
flects the recruitment of “surplus” neural capacity, while 
later developing changes are due to the expansion or in-
creased connectivity of the networks underlying these 
functions.
99)
FUTURE DIRECTIONS
While cognitive remediation approaches are promis-
ing, many questions remain. Several future directions are 
on the horizon and are briefly outlined here.
Synergy with Pharmacological Treatments
It is important to examine how one can synergistically Cognitive Remediation in Schizophrenia 131
apply pharmacologic and psychosocial approaches. 
Pharmacological agents that may have a pro-cognitive 
benefit need to be developed and tested in combination 
with cognitive remediation. In recent years, psycho-
pharmacological researchers have been increasingly 
drawn toward efforts to identify therapeutic agents that 
may address cognitive deficits in schizophrenia. The 
Measurement and Treatment Research to Improve Cogni-
tion in Schizophrenia (MATRICS) initiative has sought to 
develop cognitive batteries that are sensitive to detect 
treatment effects, and the Treatment Units for Research on 
Neurocognition in Schizophrenia (TURNS) network has 
been spearheading efforts to test potential pro-cognitive 
compounds for efficacy.
13,100) Several potential targets 
have been identified for enhancing cognition in schizo-
phrenia, including dopaminergic, serotonergic, hista-
minergic, cholinergic, glutamatergic, γ-aminobutyric acid 
(GABA)ergic, adrenergic, and sigma receptors.
101,102) For 
example, observations that individuals with schizo-
phrenia smoke at a higher rate than the general population 
have led to the theory that these individuals may be at-
tempting to “self-medicate” cognitive deficits associated 
with illness and/or antipsychotic treatment. Selective α7 
and α4β2 nicotinic receptor agonists, have shown prom-
ising, but inconsistent, results in studies to date.
103,104) 
Glutamatergic receptors, both ionotropic (NMDA, AMPA, 
and kainate-sensitive) and metabotropic (mGluR1-8) types, 
have been targeted for improving cognition.
102) Because 
glycine modulates NMDA receptor function, the glycine 
agonist D-serine is under investigation and has shown pos-
itive preliminary results, while, inhibitors of glycine reup-
take are also being studied.
105) Studies of GABAergic 
agents, such as MK-0777-a GABA (A) α2/α3 partial ag-
onist have produced conflicting results thus far.
106) 
Modafinil and d-amphetamine have promising pro-cogni-
tive effects, though their clinical use for this purpose in 
schizophrenia patients remains to be established.
107,108) It 
is an intriguing, though thus far untested, possibility that 
while pharmacological agents in and of themselves may 
have modest efficacy on cognitive deficits in schizo-
phrenia, they may prove to have synergistic effects when 
used in combination with psychosocial approaches to cog-
nitive remediation.
Non-Invasive Stimulation Techniques
Other, non-pharmacological, approaches to enhance 
neuroplasticity, such as transcranial magnetic stimulation 
(TMS)
109) and transcranial direct current stimulation 
(tDCS),
110) need to be considered as potential adjuncts to 
cognitive remediation. A recent study suggests that TMS 
applied to the prefrontal cortex may improve cognitive 
deficits in schizophrenia.
111) Similarly, anodal tDCS, ap-
plied to the dorsolateral prefrontal cortex has been shown 
to improve cognitive functions including learning and 
memory in both healthy adults and in schizophrenia 
patients.
112,113) Again, few studies have examined the po-
tential synergistic effects of these approaches with cogni-
tive remediation.
Prediction and Personalization of Treatment
Given how labor intensive such approaches are, it is es-
sential to match patients with the specific cognitive re-
mediation therapy to which they are most likely to 
respond. It is therefore critical to identify clinical, neuro-
biological, and genetic predictors of positive response to 
cognitive remediation interventions. For example, pre- 
treatment learning potential, the ability to attain and uti-
lize cognitive skills after cognitive training, is a measure 
that has been shown to predict response to cognitive 
remediation.
114) Other studies have highlighted motiva-
tion
115) and the combination of sustained attention and 
working memory as the key predictors of response, with 
the latter two factors particularly associated with general-
ized functional improvement.
116) Genetic polymorphisms 
that may mediate some aspects of cognitive function in 
schizophrenia, such as catechol-o-methyl transferase, 
have been investigated as potential predictors of outcome 
with cognitive remediation, though with inconsistent re-
sults thus far.
117,118) As research proceeds, therefore, ap-
propriate pairing of patients with the cognitive re-
mediation technique most likely to benefit them will max-
imize the likelihood of successful functional improve-
ment.
Cognitive remediation is a promising approach to im-
prove real-world functioning in patients with schizo-
phrenia. Future studies must further elucidate the neural 
mechanisms underlying cognitive remediation and de-
termine the optimal means by which to harness neuro-
plasticity. With regards to implementation, it will be im-
portant to develop cognitive remediation that can be deliv-
ered in community settings and to train front-line clini-
cians to do so. There is increasing evidence that cognitive 
remediation is most effective when combined with other 
psychosocial treatments, such as social skills training and 
supportive employment. Further work is needed to devel-
op comprehensive approaches to cognitive remediation 
that incorporate key therapeutic principles from a variety 
of treatment modalities.132 Y. Kaneko and M. Keshavan
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